14538-56-8C1CNCCN1.O=P(O)(O)ONQQWFVUVBGSGQN-UHFFFAOYSA-NSee also: Piperazinium dihydrogen phosphate (annotation moved to).
14538-56-8、1951-97-9、8057-14-5安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P203, P233, P260, P261, P264, P264+P265, P271, P272, P273, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H315: Causes skin irritation [Warning Skin corrosion/irritation]
Chemical: Piperazine, phosphate (1:1)
Chemical: Piperazine, phosphate
REACH registered substance: Piperazine, compound with phosphoric acid (EC: 217-775-8)
IMAP assessments - Piperazine salts: Human health tier II assessment
IMAP assessments - Piperazine salts: Human health tier II assessment
Skin Irrit. 2 (100%)
Eye irritation - category 2A
用途有機合成原料。
使用Piperazine Phosphate Monohydrate is used as an anthelmintic agent in the treatment of parasitic worm infections. Piperazine (P479900) derivatives are known to have high antiserotonin potency, antimicrobial activity, and potential anticancer activity in humans.
読み込み中…
DTXSID70932581CHEMBL2219733